The MediNet networking activity within ENSAR2 is dedicated to strengthen the application of nuclear-physics related knowledge, technology and expertise to advance tumour treatment and thus to address one of the questions of highest societal relevance.
The optimization of radiation therapy in general and particle therapy in particular requires research on a variety of topics such as beam delivery optimization, in-vivo monitoring of the delivered dose, dosimetry, radiobiology and radiation quality.
Expertise in nuclear techniques for the detection and characterization of charged particles and photons is crucial to each of these objectives. Large efforts are therefore devoted to the development of innovative detector technologies and modelling in several European research groups, focusing on both clinical and pre-clinical applications of particle therapy.
MediNet is providing a platform to bring together these experts for exchange of existing and development of new ideas, as well providing a training opportunity for young researchers.
Presently 25 beneficiary and 10 non-beneficiary partner institutions participate in the MediNet activity.